D. E. Shaw & Co., Inc. Staar Surgical CO Call Options Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$57.98 - $93.5 $1.33 Million - $2.15 Million	-23,000 Reduced 43.48%	29,900 $2.39 Million
Q4 2021 Feb 14, 2022	SELL	$88.02 - $127.79 $4.09 Million - $5.94 Million	-46,500 Reduced 46.78%	52,900 $4.83 Million
Q3 2021 Nov 15, 2021	BUY	$122.75 - $162.68 $1.5 Million - $1.98 Million	12,200 Added 13.99%	99,400 $12.8 Million
Q2 2021 Aug 16, 2021	BUY	$105.76 - $154.96 $5.73 Million - $8.4 Million	54,200 Added 164.24%	87,200 $13.3 Million
Q1 2021 May 17, 2021	BUY	$78.5 - $126.48 $1.81 Million - $2.91 Million	23,000 Added 230.0%	33,000 $3.48 Million
Q4 2020 Feb 16, 2021	BUY	$55.93 - $82.78 $11,186 - $16,556	200 Added 2.04%	10,000 $792,000
Q4 2018 Feb 14, 2019	SELL	$28.91 - $50.0 $456,778 - $790,000	-15,800 Reduced 61.72%	9,800 $313,000
Q3 2018 Nov 14, 2018	BUY	$30.85 - $50.65 $789,760 - $1.3 Million	25,600 New	25,600 $1.23 Million

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.1B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.